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Onychomycosis (fungal infection of the nail plate and/or nail bed) is currently mainly treated with 
oral antifungals, and topical therapy is generally only used in mild disease due to its limited success 
rate.  For a topical antifungal preparation to be effective, the drug must partition out of the 
formulation into the nail plate, diffuse through the latter and reach the nail bed in sufficient quantities 
and kill the fungus.  Thus, in in vitro studies to predict the in vivo efficacy of topical nail products, the 
most common measurements are: i) drug concentrations in the nail plate and/or a simulated nail bed, 
such as agar gel, or, ii) the fungicidal activity of the permeated drug on fungi-seeded agar gels.  There 
have been few investigations in which both drug concentrations in the nail plate, simulated nail bed 
and the antifungal inhibition have been measured together, in the same experimental setup, and where 
correlations between drug concentrations and antifungal inhibition have been explored.  This was, 
therefore, the subject of the study reported in this abstract   
 
Methods: 10µl or 10mg of three formulations – A, B and C – of an anti-fungal drug were applied on 
to the dorsal surface of excised cadaver nail plates (leaving a drug-free zone around the nail edges).  
The nail plates (thicknesses ~ 0.5mm) were then placed on agar gels seeded with Trichophyton 
mentagrophytes or T. rubrum (the most common causative organisms of onychomycosis), with the 
ventral nail surface contacting the agar gel.  The set-up was incubated at 27
o
C for 7d, after which, i) 
the diameter of the zone of fungal inhibition around the nail plate, and ii) drug concentrations in the 
nail plate and in the agar gel were determined. Correlations between fungal inhibition and drug 
concentrations were explored. 
 
Results and Discussion:  The diameter of the zones of fungal inhibition, and drug concentrations in 
the nail plate and in the agar gel (measured by HPLC) are shown in Table 1. It can be seen that the 
greatest fungal inhibition zone and highest drug concentrations were achieved with formulation B.  
Formulations A and C both showed lower drug concentrations and zones of inhibition compared to B, 
but were similar to each other.  
 
Conclusion: In general, a positive correlation was found between concentration and activity (in terms 
of fungal inhibition) of drug that had permeated through the nail plate from 3 different formulations. 
 
  Drug-in-nail  
(inside and outside 
formulation 
application area) 
(mg/g) 
Sum of Drug-in-gel 
(immediately 
underneath nail 
and 3-5mm away) 
(mg/g) 
Inhibition zone 
(mm) 
T. 
mentagrophytes 
A :10% lacquer 0.430±0.414 0.007 ± 0.004 34.3 ± 2.9 
B: 10% Gel  1.30±0.25 0.076 ± 0.080 40.5 ± 1.3 
C: 20% lacquer 0.640±0.414 0.027 ± 0.029 33.0 ± 3.6 
     
T. rubrum A :10%  lacquer 0.365±0.089 0.009  ± 0.002 24.5 ± 0.7 
B: 10% Gel  1.63±0.24 0.081 ± 0.072 31.5 ± 2.1 
C: 20% lacquer 0.403±0.083 0.013 ± 0.012 27.0 ± 1.7 
 
